Trial
NCT04365101
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Celularity Incorporated
Collaborators
Access to Advanced Health Institute (AAHI); California Institute for Regenerative Medicine (CIRM)
Condition
Coronavirus
Intervention
CYNK-001
Why stopped
Lack of enrollment due to COVID treatment options availability.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-26